Yet another study, conducted at the same centre, investigated the brain cancer cell-killing activity of the homeopathic remedy, Ruta, isolated from the plant, Ruta Graveolens. The research group treated human brain cancer and HL-60 leukaemia [blood cancer] cells, normal B-lymphoid cells, and melanoma [skin cancer] cells in mice, with different concentrations of Ruta in combination with Ca3[PO4]2, a nutritional supplement. Fifteen patients diagnosed with intracranial tumours were, likewise, treated with Ruta 6C and Ca3[PO4]2. Of the 15 patients, 6 of the 7 glioma [tumour that starts in the brain or spine] patients, showed complete regression of the tumours. One of the most exciting developments in the war on cancer was published recently in The Journal of Acupuncture and Meridian Studies. The new research shows that the homeopathic remedy, Lycopodium Clavatum — made from a spore-bearing plant belonging to the clubmoss family — has an anti-cancer effect on infected cells, while protecting normal blood cells. The research conducted by Boiron Laboratory, France, and the University of Kalyani, India, reveals that highly diluted Lycopodium Clavatum is capable of inducing ‘apoptosis’ [cellular death] in cervical cancer cells. This signifies its promising, or potential, use as a supportive, or adjuvant, therapy for cervical cancer. The annual US$200 billion dollar cancer industry is frantic — it wants to win over the argument that chemotherapy, radiation, toxic drugs and surgery are the only proven treatments for the disease. This is because conventional big pharma is confronted today
with the growing demand for complementary and alternative medicine [CAM] for cancer. This isn’t the first time that a homeopathic remedy has been found to be effective against cancer. Two previous studies have produced similarly exciting results. Frenkel, M et al used ultra-diluted remedies of Phytolacca, Carcinosin, Conium, and Thuja on breast cancer cells and witnessed a deactivation of cancer cells in a process called cytotoxicity. Yet another team, led by Toliopoulos I K, Simos Y, Bougiouklis D and Oikonomidis S, discovered that certain homeopathic complexes were able to stimulate the anti-cancer activity of natural killer cells — a part of our immune system — in cancer patients. The Banerjee Protocol — a clinical treatment foray — developed by Prasanta Banerjee et al in India, and researched in collaboration with the globally-renowned M D Anderson Cancer Center, Texas, US — cited earlier — has also proven the therapeutic efficacy of homeopathic remedies in cancer. The breakthroughs deliver the exciting prospect of homeopathy being a safe, effective and affordable adjuvant and alternative to conventional treatment. As Dr Alexander Tournier, Executive Director of the London-based Homeopathy Research Institute, confirmed the validity of the Boiron-Kalyani report, “This study is significant, performed by a well-trained team with access to modern molecular biology techniques and with the support of Boiron, a leading homeopathic manufacturer worldwide — ensuring that the homeopathy part of the experiment was taken care of correctly.” — With additional editorial inputs from Dr RAJGOPAL NIDAMBOOR
Dr Mukesh Batra, a homeopath of international repute, is Founder-Chairman, Dr Batra’s. In a career spanning four decades, Dr Batra has treated thousands of patients, including presidents and prime ministers, and revolutionised the way homeopathy is practiced today. A writer, photographer, singer and philanthropist, Dr Batra has been honoured with several fellowships and over 50 national and international awards, including the Padma Shri by the President of India. He has authored several books, including the critically-acclaimed cyclopedic work, Healing with Homeopathy. He lives in Mumbai.
12
HOMEOPATHY & YOU | MAY 2015